| Pharmaceutical compositions comprising meloxicam |
2023-4-27 |
2023-5-18 |
|
| Dosage forms and methods for enantiomerically enriched or pure bupropion |
2023-4-14 |
2023-8-10 |
|
| Dosage forms and methods for enantiomerically enriched or pure bupropion |
2023-4-13 |
2023-8-10 |
|
| Pharmaceutical compositions comprising meloxicam |
2023-3-29 |
2023-7-27 |
|
| Pharmaceutical compositions comprising meloxicam |
2023-3-17 |
2023-7-13 |
|
| Pharmaceutical compositions containing meloxicam |
2023-2-21 |
2023-5-02 |
|
| Use of reboxetine to treat narcolepsy |
2023-2-16 |
2023-3-23 |
|
| Pharmaceutical compositions comprising meloxicam |
2023-1-25 |
2023-6-08 |
|
| Pharmaceutical compositions comprising meloxicam |
2022-12-13 |
2023-4-27 |
|
| Pharmaceutical compositions comprising meloxicam |
2022-12-07 |
2023-4-06 |
|
| Methods of modulating tetrabenazine metabolites plasma levels using bupropion |
2022-11-09 |
2022-12-15 |
|
| Pharmaceutical compositions comprising meloxicam |
2022-11-01 |
2023-3-30 |
|
| Use of solid pharmaceutical compositions comprising meloxicam |
2022-10-05 |
2022-11-25 |
|
| Pharmaceutical compositions comprising meloxicam |
2022-9-22 |
2023-4-18 |
2023-4-18 |
| Pharmaceutical compositions comprising meloxicam |
2022-9-20 |
2023-9-19 |
2023-9-19 |
| Pharmaceutical compositions comprising meloxicam |
2022-9-07 |
2023-1-19 |
|
| Methods and compositions for ameliorating biomarkers associated with … |
2022-9-02 |
2023-3-09 |
|
| Pharmaceutical compositions comprising meloxicam |
2022-9-02 |
2023-1-05 |
|
| Pharmaceutical compositions comprising meloxicam |
2022-9-02 |
2023-1-05 |
|
| Dosage forms and methods for enantiomerically enriched or enantiomerically pure … |
2022-8-04 |
2022-10-12 |
|
| Pharmaceutical compositions comprising meloxicam |
2022-6-27 |
2022-10-20 |
|
| Compositions for delivery of reboxetine |
2022-6-24 |
2022-10-06 |
|
| Use of reboxetine to treat narcolepsy |
2022-6-21 |
2022-11-17 |
|
| USE OF REBOXETINE TO TREAT NERVOUS SYSTEM DISORDERS |
2022-6-17 |
2022-7-29 |
|
| Pharmaceutical compositions comprising meloxicam |
2022-6-03 |
2022-6-23 |
|
| Use of reboxetine to treat nervous system disorders |
2022-6-01 |
2022-8-01 |
|
| Reboxetine to treat narcolepsy |
2022-5-23 |
2022-9-08 |
|
| Dosage forms and methods for enantiomerically enriched or pure bupropion |
2022-4-26 |
2022-8-11 |
|
| DOSAGE FORMS AND METHODS FOR ENANTIOMERICALLY ENRICHED OR PURE BUPROPION |
2022-4-13 |
2022-5-31 |
|
| Methods of modulating tetrabenazine metabolites plasma levels using bupropion |
2022-3-10 |
2022-6-23 |
|
| Dosage forms and methods for enantiomerically enriched or pure bupropion |
2022-3-10 |
2022-6-23 |
|
| Pharmaceutical compositions comprising meloxicam |
2022-2-25 |
2022-7-28 |
|
| Pharmaceutical compositions comprising meloxicam |
2022-2-23 |
2022-6-09 |
|
| Pharmaceutical compositions comprising meloxicam |
2022-1-29 |
2022-3-17 |
|
| Solid pharmaceutical compositions comprising meloxicam |
2022-1-20 |
2022-3-10 |
|
| Pharmaceutical composition comprising meloxicam |
2021-12-29 |
2023-8-29 |
|
| Pharmaceutical compositions comprising meloxicam |
2021-12-13 |
2022-9-06 |
2022-9-06 |
| Pharmaceutical compositions comprising meloxicam |
2021-12-07 |
2022-9-06 |
2022-9-06 |
| Use of esreboxetine to treat nervous system disorders such as fibromyalgia |
2021-11-29 |
2022-8-11 |
|
| Pharmaceutical compositions comprising meloxicam |
2021-11-02 |
2022-2-24 |
|
| Pharmaceutical compositions comprising meloxicam |
2021-9-24 |
2022-1-13 |
|
| Pharmaceutical compositions comprising meloxicam |
2021-9-08 |
2021-12-30 |
|
| Pharmaceutical compositions comprising meloxicam |
2021-9-03 |
2021-12-23 |
|
| Pharmaceutical compositions comprising meloxicam |
2021-8-17 |
2021-12-02 |
|
| Pharmaceutical compositions comprising meloxicam |
2021-8-13 |
2021-12-02 |
|
| Pharmaceutical compositions comprising meloxicam |
2021-7-21 |
2021-11-11 |
|
| Pharmaceutical compositions comprising meloxicam |
2021-6-28 |
2022-6-14 |
2022-6-14 |
| Pharmaceutical compositions comprising meloxicam |
2021-5-20 |
2022-3-29 |
2022-3-29 |
| Pharmaceutical compositions comprising meloxicam |
2021-5-13 |
2021-8-26 |
|
| Pharmaceutical compositions comprising meloxicam |
2021-5-12 |
2022-3-29 |
2022-3-29 |
| Pharmaceutical compositions comprising meloxicam |
2021-4-06 |
2021-10-14 |
|
| Dosage forms and methods for enantiomerically enriched or pure bupropion |
2021-2-26 |
2021-6-17 |
|
| Dosage forms and methods for enantiomerically enriched or pure bupropion |
2021-2-24 |
2021-7-01 |
|
| Pharmaceutical compositions comprising meloxicam |
2021-2-24 |
2021-7-01 |
|
| PHARMACEUTICAL COMPOSITIONS INCLUDING MELOXICAM |
2021-1-29 |
2021-2-26 |
|
| Pharmaceutical compositions comprising meloxicam |
2021-1-11 |
2021-12-28 |
2021-12-28 |
| Pharmaceutical compositions comprising meloxicam |
2020-12-15 |
2022-1-11 |
2022-1-11 |
| Use of reboxetine to treat narcolepsy |
2020-12-09 |
2021-4-08 |
|
| USE OF REBOXETINE TO TREAT NERVOUS SYSTEM DISORDERS |
2020-12-02 |
2022-9-07 |
|
| Bupropion as a modulator of drug activity |
2020-10-15 |
2021-9-21 |
2021-9-21 |
| Bupropion as a modulator of drug activity |
2020-10-14 |
2021-9-28 |
2021-9-28 |
| Compositions for delivery of reboxetine |
2020-10-06 |
2021-1-21 |
|
| Dosage forms and methods for enantiomerically enriched or pure bupropion |
2020-7-09 |
2021-11-23 |
2021-11-23 |
| Dosage forms and methods for enantiomerically enriched or pure bupropion |
2020-6-22 |
2022-9-06 |
2022-9-06 |
| Pharmaceutical compositions comprising meloxicam |
2020-4-24 |
2021-4-27 |
2021-4-27 |
| Pharmaceutical compositions comprising meloxicam |
2020-4-21 |
2020-8-20 |
|
| Pharmaceutical compositions comprising meloxicam |
2020-4-09 |
2020-9-22 |
2020-9-22 |
| Pharmaceutical compositions comprising meloxicam |
2020-4-08 |
2020-9-01 |
2020-9-01 |
| Pharmaceutical compositions comprising meloxicam |
2020-4-07 |
2020-8-06 |
|
| Pharmaceutical compositions comprising meloxicam |
2020-4-06 |
2020-7-23 |
|
| Pharmaceutical compositions comprising meloxicam |
2020-4-01 |
2020-9-22 |
2020-9-22 |
| Pharmaceutical compositions comprising meloxicam |
2020-3-31 |
2020-7-23 |
|
| Pharmaceutical compositions comprising meloxicam |
2020-3-30 |
2020-7-16 |
|
| Dosage forms and methods for enantiomerically enriched or pure bupropion |
2020-3-27 |
2022-5-17 |
2022-5-17 |
| Dosage forms and methods for enantiomerically enriched or pure bupropion |
2020-3-26 |
2020-7-16 |
|
| Pharmaceutical compositions comprising meloxicam |
2020-2-13 |
2020-6-11 |
|
| PHARMACEUTICAL COMPOSITIONS INCLUDING MELOXICAM |
2020-2-06 |
2021-10-05 |
|
| Pharmaceutical compositions comprising meloxicam |
2020-2-06 |
2020-8-13 |
|
| Pharmaceutical compositions comprising meloxicam |
2020-1-27 |
2020-7-07 |
2020-7-07 |
| Pharmaceutical compositions comprising meloxicam |
2019-11-25 |
2020-7-07 |
2020-7-07 |
| Pharmaceutical compositions comprising meloxicam |
2019-11-22 |
2020-3-19 |
|
| Pharmaceutical compositions comprising meloxicam |
2019-11-21 |
2020-6-30 |
2020-6-30 |
| Pharmaceutical compositions comprising meloxicam |
2019-11-20 |
2020-6-23 |
2020-6-23 |
| Pharmaceutical compositions comprising meloxicam |
2019-11-19 |
2020-3-19 |
|
| Pharmaceutical compositions comprising meloxicam |
2019-10-15 |
2020-2-06 |
|
| Dosage forms comprising active pharmaceutical ingredients |
2019-9-26 |
2023-9-14 |
|
| Dosage forms and methods for enantiomerically enriched or pure bupropion |
2019-9-23 |
2020-3-26 |
|
| Pharmaceutical compositions comprising meloxicam |
2019-9-16 |
2020-8-04 |
2020-8-04 |
| Pharmaceutical compositions comprising meloxicam |
2019-9-13 |
2020-1-02 |
|
| Pharmaceutical compositions comprising meloxicam |
2019-9-13 |
2020-8-04 |
2020-8-04 |
| Pharmaceutical compositions comprising meloxicam |
2019-9-12 |
2020-8-04 |
2020-8-04 |
| Pharmaceutical compositions comprising meloxicam |
2019-9-11 |
2019-12-31 |
2019-12-31 |
| Pharmaceutical compositions comprising meloxicam |
2019-9-10 |
2020-1-02 |
|
| Pharmaceutical compositions comprising meloxicam |
2019-9-09 |
2020-1-14 |
2020-1-14 |
| Methods of modulating tetrabenazine metabolites plasma levels using bupropion |
2019-7-16 |
2019-12-12 |
|
| Combination treatment for migraine and other pain |
2019-7-16 |
2019-11-07 |
|
| Pharmaceutical compositions comprising meloxicam |
2019-6-27 |
2019-10-17 |
|
| Pharmaceutical compositions comprising meloxicam |
2019-6-13 |
2019-10-10 |
|
| Pharmaceutical compositions comprising meloxicam |
2019-5-03 |
2019-8-22 |
|
| Neridronic acid and other bisphosphonates for treating complex regional pain … |
2019-3-27 |
2019-7-18 |
|